Protara Therapeutics Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Progress ESPR Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Undisclosed NNI Q1 2026 Earnings EPS Misses Estimates by 2782 C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Amid Continued Pipeline Progress TRINZ Q1 2026 Earnings Modest EPS Beat Amid Stable Revenue Outlook RYAAY Q1 2026 Earnings EPS Misses Widely Yet Shares Rally